Australia to receive 15,000 doses of COVID-19 treatment drug Ronapreve
Australia has secured a deal to receive 15,000 doses of a COVID-19 drug named Ronapreve which will assist hospitals in treating patients with severe illness.
The antibody-based therapy from Roche Products is expected to be available by the end of the month, pending regulatory approval.
Ronapreve is used to help treat COVID-19 positive patients who have no effective immune system, and will help those who contract the virus despite being unvaccinated.
READ MORE: Victoria records 1838 new COVID-19 cases, seven new deaths as state awaits reopening timeline
READ MORE: NSW records 301 new COVID-19 cases as restrictions set to ease tomorrow
Chief Medical Officer Professor Paul Kelly said from midnight Tuesday October 19, quarantine-free international travel from the South Island of New Zealand will resume. Nine
Health Minister Greg Hunt said nationally, Australia has hit a first-dose vaccination rate of 84.6 per cent.
Nationally the fully vaccinated rate now sits at 67.8 per cent.
Chief Medical Officer Professor Paul Kelly said from midnight Tuesday October 19, quarantine-free international travel from the South Island of New Zealand will resume.
No date has been set for the country's North Island.
The treatment will assist patients in hospital with the virus. Associated Press
More to come …
Share a tip-off, video or photo with us
Most viewed in Australia
Australian woman who died after falling from cliff near Bali was Queensland ecologist
PM ‘stunned’ over Pauline Hanson’s attack on his late mother
Six years ago, Australia had a $38 billion early super experiment. It didn’t go to plan
Tony Abbott’s ex-chief of staff says she wanted Julia Gillard to succeed
